A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn's Disease Improves Outcomes at 2 Years.

Giulia D'Arcangelo,Giusy Russo,Marina Aloi,Cosimo Ruggiero,Francesca Maccioni,Cesare Hassan,Paola Papoff,Stanley Allen Cohen,Salvatore Oliva

Inflammatory bowel diseases（2023）

引用 0|浏览8

暂无评分

摘要

When a PCE-based, treat-to-target strategy is employed, MH is sustainable (93%) over a 1-year period and is correlated with improved patient outcomes, including reduced need for steroids, treatment escalation, hospitalization, and clinical relapses at 104 weeks.ClinicalTrials.gov number: NCT03161886.

查看译文

关键词

Crohn’s disease,mucosal healing,pan-enteric capsule endoscopy,treat-to-target

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要